A functional polymorphism C-1310G in the promoter region of Ku70/XRCC6 is associated with risk of renal cell carcinoma

Molecular Carcinogenesis

Volumn 51, Issue SUPPL. 1, 2012, Pages

  Wang, Wei ^a,b   Pan, Xuping ^a   Huo, Xinying ^b   Yan, Fu ^b   Wang, Meilin ^a,b   Wang, Dingxian ^a   Gao, Yanqin ^a   Cao, Qiang ^c   Luo, Dewei ^b   Qin, Chao ^c   Yin, Changjun ^c   Zhang, Zhengdong ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Genetic variation; Ku70 XRCC6; Molecular epidemiology; Renal cell carcinoma; Survival

Indexed keywords

KU ANTIGEN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG; XRCC6 PROTEIN;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; DISEASE ASSOCIATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOMIC INSTABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SMOKING;

ADULT; AGED; ANTIGENS, NUCLEAR; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CELL LINE; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; LUCIFERASES; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SURVIVAL RATE;

EID: 84867139395     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21914     Document Type: Article

References (34)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7-33.
2. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005; 14: 243-250.
3. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol 2006; 176: 2353-2358.
4. Setiawan VW, Stram DO, Nomura AM, Kolonel LN, Henderson BE. Risk factors for renal cell cancer: The multiethnic cohort. Am J Epidemiol 2007; 166: 932-940.
5. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies. Int J Cancer 2005; 114: 101-108.
6. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 2010; 31: 1805-1812.
7. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001; 291: 1284-1289.
8. Yu Z, Chen J, Ford BN, Brackley ME, Glickman BW. Human DNA repair systems: An overview. Environ Mol Mutagen 1999; 33: 3-20.
9. Khanna KK, Jackson SP. DNA double-strand breaks: Signaling, repair and the cancer connection. Nat Genet 2001; 27: 247-254.
10. Jackson SP, Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002; 23: 687-696.
11. Han J, Colditz GA, Samson LD, Hunter DJ. Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res 2004; 64: 3009-3013.
12. Bau DT, Fu YP, Chen ST, et al. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Cancer Res 2004; 64: 5013-5019.
13. Bau DT, Mau YC, Ding SL, Wu PE, Shen CY. DNA double-strand break repair capacity and risk of breast cancer. Carcinogenesis 2007; 28: 1726-1730.
14. Willems P, Claes K, Baeyens A, et al. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. Genes Chromosomes Cancer 2008; 47: 137-148.
15. Chiu CF, Wang CH, Wang CL, et al. A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Ann Surg Oncol 2008; 15: 514-518.
16. Chiu CF, Tsai MH, Tseng HC, et al. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 2008; 44: 898-902.
17. Wang SY, Peng L, Li CP, et al. Genetic variants of the XRCC7 gene involved in DNA repair and risk of human bladder cancer. Int J Urol 2008; 15: 534-539.
18. Hirata H, Hinoda Y, Matsuyama H, et al. Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem Biophys Res Commun 2006; 342: 1058-1062.
19. Willems P, De Ruyck K, Van den Broecke R, et al. A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure. J Cancer Res Clin Oncol 2009; 135: 1159-1168.
20. Bau DT, Tseng HC, Wang CH, et al. Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. Oral Oncol 2008; 44: 1047-1051.
21. Yang MD, Wang HC, Chang WS, Tsai CW, Bau DT. Genetic polymorphisms of DNA double strand break gene Ku70 and gastric cancer in Taiwan. BMC Cancer 2011; 11: 174-179.
22. Zhu J, Qin C, Wang M, et al. Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma. Mol Carcinog 49: 810-817.
23. Wang M, Zhang Z, Zhu H, et al. A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population. Clin Cancer Res 2008; 14: 3633-3640.
24. Fu YP, Yu JC, Cheng TC, et al. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: A multigenic study on cancer susceptibility. Cancer Res 2003; 63: 2440-2446.
25. McLaughlin JK, Lipworth L. Epidemiologic aspects of renal cell cancer. Semin Oncol 2000; 27: 115-123.
26. Lee JE, Hunter DJ, Spiegelman D, et al. Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst 2007; 99: 801-810.
27. Hosoi Y, Watanabe T, Nakagawa K, et al. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 2004; 25: 461-468.
28. Hasan NM, MacDonald MJ. Sp/Kruppel-like transcription factors are essential for the expression of mitochondrial glycerol phosphate dehydrogenase promoter B. Gene 2002; 296: 221-234.
29. Chen C, Bhalala HV, Qiao H, Dong JT. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 2002; 21: 6567-6572.
30. Rozenblum E, Vahteristo P, Sandberg T, et al. A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: Identification and characterization of candidate genes. Hum Genet 2002; 110: 111-121.
31. Jemal A, Murray T, Ward E, et al. Cancer statistics 2005. CA Cancer J Clin 2005; 55: 10-30.
32. Senan S, Smit EF. Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist 2007; 12: 465-477.
33. Wilson CR, Davidson SE, Margison GP, Jackson SP, Hendry JH, West CM. Expression of Ku70 correlates with survival in carcinoma of the cervix. Br J Cancer 2000; 83: 1702-1706.
34. Lee SW, Cho KJ, Park JH, et al. Expressions of Ku70 and DNA-PKcs as prognostic indicators of local control in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2005; 62: 1451-1457.